We are live on ! Find out more
MCM

Marathon Capital Management Portfolio holdings

AUM $494M
1-Year Est. Return 42.6%
This Fund
S&P 500
This Quarter Est. Return
+7.26%
1 Year Est. Return
+42.6%
3 Year Est. Return
+70.91%
5 Year Est. Return
+55.81%
10 Year Est. Return
+429.8%
AUM
$465M
AUM Growth
+$27.7M
Cap. Flow
+$3.84M
Cap. Flow %
0.83%
Top 10 Hldgs %
38.98%
Holding
176
New
13
Increased
40
Reduced
76
Closed
5

Top Sells

Rank Stock Value
1
TROW icon
T. Rowe Price
TROW
+$3.25M
2
SLB icon
SLB Ltd
SLB
+$2.76M
3
CPA icon
Copa Holdings
CPA
+$2.42M
4
BAC.PRL icon
Bank of America Series L
BAC.PRL
+$954K
5
GLW icon
Corning
GLW
+$733K

Sector Composition

Rank Sector Weight
1 Financials 22.72%
2 Technology 20.28%
3 Healthcare 14.33%
4 Industrials 10.95%
5 Energy 6.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
B
26
Barrick Mining
B
$68.8B
$5.65M 1.22%
129,825
-5,865
-4% -$220K
ANIP icon
27
ANI Pharmaceuticals
ANIP
$1.88B
$5.5M 1.18%
69,665
-40
-0.1% -$3.46K
WTW icon
28
Willis Towers Watson
WTW
$31.3B
$5.45M 1.17%
16,580
-83
-0.5% -$27.2K
JNJ icon
29
Johnson & Johnson
JNJ
$617B
$5.42M 1.17%
26,186
-2,550
-9% -$504K
DHR icon
30
Danaher
DHR
$139B
$5.27M 1.14%
23,039
-395
-2% -$86.8K
ALM
31
Almonty Industries
ALM
$3.88B
$5.23M 1.13%
593,515
+343,280
+137% +$2.52M
ACA icon
32
Arcosa
ACA
$7.12B
$5.05M 1.09%
47,525
+210
+0.4% +$21.2K
ADBE icon
33
Adobe
ADBE
$102B
$4.58M 0.99%
13,081
+624
+5% +$212K
ZETA icon
34
Zeta Global
ZETA
$6.39B
$4.52M 0.97%
221,905
+3,295
+2% +$61.5K
ZTS icon
35
Zoetis
ZTS
$32.8B
$4.42M 0.95%
+35,150
New +$4.58M
GLD icon
36
SPDR Gold Trust
GLD
$137B
$4.35M 0.94%
10,988
-360
-3% -$137K
CALX icon
37
Calix
CALX
$2.38B
$4.27M 0.92%
80,585
+385
+0.5% +$22.4K
NPKI
38
NPK International
NPKI
$1.16B
$4.26M 0.92%
357,390
-30,960
-8% -$378K
NVO
39
Novo Nordisk
NVO
$200B
$4.21M 0.91%
82,705
+25,230
+44% +$1.29M
ATEC icon
40
Alphatec Holdings
ATEC
$1.41B
$4.18M 0.9%
198,900
-2,025
-1% -$37.5K
DOC icon
41
Healthpeak Properties
DOC
$14.6B
$3.98M 0.86%
247,542
-12,524
-5% -$221K
CB icon
42
Chubb
CB
$136B
$3.98M 0.86%
12,740
+140
+1% +$40.9K
MRK icon
43
Merck
MRK
$317B
$3.54M 0.76%
33,665
-487
-1% -$45.7K
ARCC icon
44
Ares Capital
ARCC
$14.1B
$3.33M 0.72%
164,845
+7,125
+5% +$144K
PAR icon
45
PAR Technology
PAR
$704M
$2.79M 0.6%
76,835
+9,240
+14% +$333K
LLY icon
46
Eli Lilly
LLY
$1.05T
$2.74M 0.59%
2,548
-35
-1% -$33.5K
GOOGL icon
47
Alphabet (Google) Class A
GOOGL
$4.39T
$2.45M 0.53%
7,835
+550
+8% +$157K
MU icon
48
Micron Technology
MU
$1.02T
$2.37M 0.51%
8,295
-1,415
-15% -$325K
SYM icon
49
Symbotic
SYM
$5.28B
$2.35M 0.51%
39,570
+55
+0.1% +$3.63K
PG icon
50
Procter & Gamble
PG
$340B
$2.33M 0.5%
16,293
-664
-4% -$97.9K

Similar funds

Marathon Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Marathon Capital Management held 176 positions worth $465M, up 6.3% from $437M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Marathon Capital Management's Q4 2025 filing shows 13 new, 40 increased, 76 reduced and 5 closed positions. Its largest new stake was Zoetis: 35,150 shares worth $4.42M. The largest sale was T. Rowe Price, an estimated $3.25M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.

  • Marathon Capital Management's largest Q4 2025 buy was Zoetis: 35,150 shares worth $4.42M.
  • Marathon Capital Management added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q4 2025, an estimated $3.56M increase.
  • Marathon Capital Management's biggest Q4 2025 reduction was T. Rowe Price, cutting an estimated $3.25M.
  • Marathon Capital Management fully exited Civitas Resources in Q4 2025, selling an estimated $328K.
  • Marathon Capital Management's ten largest holdings make up 39% of its $465M portfolio in Q4 2025.
  • Marathon Capital Management opened 13 new positions and closed 5 in Q4 2025.
  • Marathon Capital Management's portfolio value rose 6.3% quarter-over-quarter to $465M.

Based on Marathon Capital Management's 13F filing for Q4 2025, filed 29 Jan 2026.